Leflunomide for the Treatment of Relapsed or Refractory CD30+ Lymphoproliferative Disorders
Clinical trial NCT04463615 · COMPLETED
Trial details
- NCT number
- NCT04463615
- Sponsor
- City of Hope Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-05
- Primary completion
- 2021-07-28
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.